Early Stage

tech scrubs that turn customers into shareholders

tech scrubs that turn customers into shareholders


Funding data not publicly available

Rialto Markets

Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common



SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Pre-Money Valuation


Year Founded



Apparel & Fashion

Tech Sector


Distribution Model




Capital Intensity



El Monte, California

Business Type


Ouragins, with a valuation of $18.9 million, is raising funds on Rialto Markets. The company makes science-backed scrubs using antimicrobial tech fabrics. The fabrics of Ouragins scrubs are soft, breathable, come with 4-way stretch, and move seamlessly with the customers. Ouragins is led by an experienced team and has been featured in Yahoo, Men’s Health, and Business Insider. Shaun Veran founded Ouragins in July 2020. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,200,000. The campaign proceeds will be used for product development, tech and data science, sales and marketing, and new hires.

Summary Profit and Loss Statement

Most Recent Year Prior Year












Net Income



Summary Balance Sheet

Most Recent Year Prior Year




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 08/28/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Ouragins 04/29/2023 Rialto Markets $18,935,379 - Equity - Common Funded RegCF
Ouragins 04/02/2022 Rialto Markets $12,791,768 $146,312 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Founder Profile

Ouragins CEO Shaun Veran on Giving Back to Healthcare Professionals

You’d be hard-pressed to find a medical uniform more iconic than the scrub. Starting out in operating rooms in the 1950s, scrubs quickly became the clothing of choice for medical professionals of every specialty. They’re lightweight, easy to clean, and can even be antimicrobial to fight the spread of disease. 

Ouragins has updated and improved the traditional scrub. Its design features copper threading and advanced antimicrobial technology to help fight bacterial spread in the wake of the COVID-19 pandemic. We spoke with CEO Shaun Veran about how Ouragins is taking scrubs into the future and how the company is giving back to its most loyal customers.

Note: This interview was conducted over phone and email. It has been lightly edited for clarity and length.

Read Founder Interview

Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Ouragins on Rialto Markets 2022
Platform: Rialto Markets
Security Type: Equity - Common
Valuation: $18,935,379
Price per Share: $2.40

Follow company

Follow Ouragins on Rialto Markets 2022

Buy Ouragins's Deal Report

Warning: according to the close date for this deal, Ouragins may no longer be accepting investments.

Ouragins Deal Report

Get KingsCrowd’s comprehensive report on Ouragins including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Ouragins is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Ouragins deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge